International collaboration led by researchers at the Sant Pau Reseach Institute – IIB Sant Pau in Barcelona, Spain, shows effectiveness of a plasma biomarker to detect Alzheimer’s Disease in Down syndrome individuals. Their results, which have been published in Nature Communications, will enhance diagnostic capability in this particular population. In parallel, researchers have also published another study in JAMA Neurology where they analyzed the influence of the most important genetic factor for Alzheimer’s disease (APOE) on the mechanisms of this pathology in the population with Down syndrome
.
Last update: 27 de July de 2021
